Table 2

Effects of individualised, evidence-based counselling on treatment rate and adherence to treatment

Outcome variablesControlInterventionOR (95% CI)
NumberEvents (%)*NumberEvents (%)*
Use of antihypertensive drugs
 Baseline10763 (58.9)10368 (66.0)1.36 (0.77 to 2.38)
 2-week follow-up10563 (58.9)10068 (66.0)1.36 (0.77 to 2.38)
 3-month follow-up10169 (64.5)9767 (65.0)1.02 (0.58 to 1.81)
 6-month follow-up9862 (57.9)9567 (65.0)1.35 (0.77 to 2.36)
Good adherence
 Baseline10743 (40.2)10348 (46.6)1.30 (0.75 to 2.24)
 2-week follow-up10544 (41.1)10050 (49.5)1.35 (0.78 to 2.33)
 3-month follow-up10150 (46.7)9745 (43.7)0.88 (0.51 to 1.52)
 6-month follow-up9843 (40.2)9545 (43.7)1.15 (0.67 to 2.00)
  • *Percentages were calculated following the ‘intention-to-treat’ principle.

  • CI, confidence interval; OR, odds ratio.